Log In
Print this Print this

octreotide (NSI-2)

  Manage Alerts
Collapse Summary General Information
Company Nanosion Co. Ltd.
DescriptionModified liposome formulation of octreotide
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentDiscovery
Standard Indication Cancer (unspecified)
Indication DetailsTreat refractory or metastatic cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today